ADIPONECTIN LEVEL IN PATIENTS WITH METABOLIC SYNDROME WHO HAVE EXPERIENCED ACUTE CEREBRAL CIRCULATORY DISORDERS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper shows the association of adiponectin having multifunctional activity with the main anthropometric and biochemical parameters of metabolic syndrome and with the degree of atherosclerosis in patients.

Full Text

Restricted Access

About the authors

V. Shishkova

Center for Speech Pathology and Neurorehabilitation

Email: veronika-1306@mail.ru
Candidate of Medical Sciences

A. Remennik

Center for Speech Pathology and Neurorehabilitation

Candidate of Medical Sciences

References

  1. Метаболический синдром / под ред. Г. Е. Ройтберга - М.: Медпрессинформ, 2007. - C. 224.
  2. Cao Y., Tao L., Tuan Y. et al. Endothelial dysfunction in adiponectin deficiency and its mechanisms involed // J. Mol. Cell. Cardiol. - 2009; 46: 413-419.
  3. Krenning G., Moonen J., Harmsen V. Pleriotropism of adiponectin: inflammation, neovascularization, and fibrosis // Circ. Res. - 2009; 104: 1029-1031.
  4. Ouchi N., Walsh K. A Nоvel role for adiponectin in the regulation of inflammation // Arterioscler. Tromb. Vasc. Biol. - 2008; 28: 1229-1221.
  5. Rabin K., Kamari Y., Avni I. et al. Adiponectin: linking the metabolic syndrome to its cardiovascular consequences // Exp. Rev. Cardiovasc. Ther. -2005; 3: 465-471.
  6. Чазова И. Е. Национальные рекомендации по диагностике и лечению метаболического синдрома // Кардиоваскулярная терапия и профилактика. -2007; 6 (6); Приложение 2.
  7. Tan K., Xu A., Chow W. et al. Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation // J. Clin. Endocrinol. Metab. - 2004; 89: 765-769.
  8. Bang O., Saver J., Ovbiagele B. et al. Adiponectin levels in patients with intracranial atherosclerosis // Neurology. - 2007; 68: 1931-1937.
  9. Okui H., Hamasaki S., Ishida S. et al. Adiponectin is a better predictor of endothelial function of the coronary artery than HOMA-R, body mass index, immunoreactive insulin, or triglycerides // Int. J. Cardiol. - 2008; 126: 53-61.
  10. Selcuk M., Selcuk H., Temizhan A. et al. Impact of plasma adiponectin levels to the presence and severity of coronary artery disease in patients with metabolic syndrome // Coron. Artery. Dis. - 2008; 19: 79-84.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2012 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies